Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Meta-Analysis
. 2024 Jun;271(6):3039-3049.
doi: 10.1007/s00415-024-12353-w. Epub 2024 Apr 10.

Endovascular thrombectomy with versus without intravenous thrombolysis in patients with acute basilar artery occlusion: a systematic review and meta-analysis

Lingyu Cai #  1 , Liaoyuan Wang #  2 , Bruce C V Campbell  3 , Yuelu Wu  1 , Mohamad Abdalkader  4 , Fana Alemseged  3 , Johannes Kaesmacher  5 , Volker Puetz  6 , Simon Nagel  7 , Daniel Strbian  8 , Robrecht R M M Knapen  9 , Chuanhui Li  10 , Shitai Ye  1 , Pengli Tian  1 , Jingjing Chen  1 , Ruitian Li  11 , Wei Hu  12 , Zhongming Qiu  1 , Thanh N Nguyen  4 , Wouter J Schonewille  13 , Qifeng Guo  14 , Zhao Dai  15
Affiliations
Meta-Analysis

Endovascular thrombectomy with versus without intravenous thrombolysis in patients with acute basilar artery occlusion: a systematic review and meta-analysis

Lingyu Cai et al. J Neurol. 2024 Jun.

Abstract

Background and purpose: The benefit and safety of intravenous thrombolysis before endovascular thrombectomy in patients with acute ischemic stroke caused by basilar artery occlusion (BAO) remains unclear. This article aims to investigate the clinical outcomes and safety of endovascular thrombectomy with versus without intravenous thrombolysis in acute BAO stroke patients.

Methods: We conducted a comprehensive search of PubMed, Embase, Cochrane, and Web of Science databases to identify relevant literature pertaining to patients with acute BAO who underwent endovascular thrombectomy alone or intravenous thrombolysis bridging with endovascular thrombectomy (bridging therapy), until January 10, 2024. The primary outcome was functional independence, defined as a score of 0-2 on the modified Rankin Scale at 90 days. The safety outcome was mortality at 90 days and symptomatic intracranial hemorrhage within 48 h. Effect sizes were computed as risk ratio (RR) with random-effect models. This study was registered in PROSPERO (CRD42023462293).

Results: A total of 528 articles were obtained through the search and articles that did not meet the inclusion criteria were excluded. Finally, 2 RCTs and 10 cohort studies met the inclusion criteria. The findings revealed that the endovascular thrombectomy alone group had a lower rate of functional independence compared to the bridging therapy group (29% vs 38%; RR 0.78, 95% CI 0.68-0.88, p < 0.001), lower independent ambulation (39% vs 45%; RR 0.89, 95% CI 0.82-0.98, p = 0.01), and higher mortality (36% vs 28%, RR 1.22, 95% CI 1.08-1.37, p = 0.001). However, no differences were detected in symptomatic intracranial hemorrhage between the two groups (6% vs 4%; RR 1.12, 95% CI 0.74-1.71, p = 0.58).

Conclusion: Intravenous thrombolysis plus endovascular thrombectomy seemed to led to better functional independence, independent ambulation, and lower risk of mortality without increasing the incidence of intracranial hemorrhage compared to endovascular thrombectomy alone. However, given the non-randomized nature of this study, further studies are needed to confirm these findings.

Keywords: Acute ischemic stroke; Basilar artery occlusion; Endovascular thrombectomy; Intravenous thrombolysis; Meta-analysis.

PubMed Disclaimer

References

    1. Powers WJ, Rabinstein AA, Ackerson T, Adeoye OM, Bambakidis NC, Becker K et al (2019) Guidelines for the early management of patients with acute ischemic stroke: 2019 update to the 2018 guidelines for the early management of acute ischemic stroke: a guideline for healthcare professionals from the American heart association/American stroke association. Stroke 50:e344–e418 - PubMed
    1. Masoud HE, Havenon Ad, Castonguay AC, Asif KS, Nguyen TN, Mehta B et al (2022) brief practice update on intravenous thrombolysis before thrombectomy in patients with large vessel occlusion acute ischemic stroke: a statement from society of vascular and interventional neurology guidelines and practice standards (gaps) committee. Stroke Vascular Intervent Neurol 2022(2):000276
    1. Bhatia R, Hill MD, Shobha N, Menon B, Bal S, Kochar P et al (2010) Low rates of acute recanalization with intravenous recombinant tissue plasminogen activator in ischemic stroke: real-world experience and a call for action. Stroke 41:2254–2258 - PubMed
    1. Campbell BCV, Mitchell PJ, Churilov L, Yassi N, Kleinig TJ, Dowling RJ et al (2018) Tenecteplase versus alteplase before thrombectomy for ischemic stroke. N Engl J Med 378:1573–1582 - PubMed
    1. Yogendrakumar V, Beharry J, Churilov L, Alidin K, Ugalde M, Pesavento L et al (2023) Tenecteplase improves reperfusion across time in large vessel stroke. Ann Neurol 93:489–499 - PubMed

MeSH terms

Substances

LinkOut - more resources